Riskpilot← Back to searchSign inGet full accessMedijohn AB
ABActiveOrg 5569525065Gustav Iii:S Boulevard 42General medical practice activities · NACE 8621Est. 201312 employees
Revenue 2024
SEK 33,3M
+6% vs 2023
EBITDA margin
58.1%
+12% vs 2023
Equity ratio
61.4%
Financial strength
Net profit 2024
SEK 13M
+20% vs 2023
| Revenue | SEK 33,3M | +6% |
| EBITDA | SEK 19,4M | +12% |
| Net profit | SEK 13M | +20% |
| Total assets | SEK 54,4M | +31% |
| Equity | SEK 33,4M | +39% |
| Employees | 12 | — |
Legal name
Medijohn AB
Org number
5569525065
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 december 2013
Share capital
SEK 50 000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva husläkarmottagning innefattande primärvård, hemsjukvård och hälsovård samt därmed förenlig verksamhet. Bolaget ska därtill bedriva uthyrning av personal.
Address
Gustav Iii:S Boulevard 42
Email
drsamisweden@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 18 257 | 22 343 | 25 743 | 29 984 | 30 191 | 31 520 | 33 325 |
| Staff expenses | — | — | — | — | — | — | — | −10 480 | — | −10 519 |
| EBITDA | — | −15 | 3 326 | 6 346 | 5 046 | 11 014 | 8 541 | 16 654 | 17 307 | 19 365 |
| Depreciation & amort. | −0 | −0 | −219 | −178 | −270 | −270 | −224 | −185 | −158 | −111 |
| EBIT | 0 | −15 | 3 107 | 6 168 | 4 776 | 10 744 | 8 317 | 16 469 | 17 149 | 19 254 |
| Net financials | — | — | −22 | −30 | −4 | −14 | −2 | −1 | 276 | 710 |
| Profit before tax | 0 | −15 | 2 317 | 4 594 | 3 572 | 8 131 | 6 314 | 12 468 | 13 692 | 16 510 |
| Tax | −0 | −0 | −507 | −1 019 | −772 | −1 750 | −1 308 | −2 580 | −2 883 | −3 508 |
| Net profit | 0 | −15 | 1 810 | 3 575 | 2 800 | 6 381 | 5 006 | 9 888 | 10 809 | 13 001 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 50 | 847 | 4 701 | 10 555 | 14 301 | 17 741 | 22 538 | 32 002 | 41 452 | 54 385 |
| Equity | 50 | 35 | 2 645 | 4 919 | 6 919 | 8 300 | 10 307 | 16 595 | 24 004 | 33 405 |
| Long-term debt | 0 | 800 | 0 | 0 | 0 | 0 | 0 | — | 0 | — |
| Short-term debt | 0 | 12 | 1 289 | 3 323 | 3 869 | 3 328 | 4 119 | 3 294 | 1 603 | 1 679 |
| Total debt | — | 812 | 1 289 | 3 323 | 3 869 | 3 328 | 4 119 | 3 294 | 1 603 | 1 679 |
EBITDA margin
58.1%
This company
15.8%
Market median
+268% vs market
20152024
Equity ratio
61.4%
This company
38.2%
Market median
+61% vs market
20152024
Return on equity
38.9%
This company
18.4%
Market median
+111% vs market
20152024
Net profit margin
39.0%
This company
8.1%
Market median
+381% vs market
20152024
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20152024
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-07-01 – 2015-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MM Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
BF Audit | Audit | 2022 | — | — |
AK | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medijohn AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marianne Magdi Tawfik Hanna | Chief Executive Officer | 0 companies |
| Björn Fredrik Åborg | Audit | 0 companies |
| Anna Kristina Stenberg | Audit | 0 companies |
| Sami Edward Azez Nachid | Board of Directors | 0 companies |
| Ulf Oscar Hållmarker | Chairman | 0 companies |